Primary Relief
Stimulator, Nerve, Electrical, Percutaneous (Pens), For Pain Relief. 510(k) K221425, from Dyansys, Inc. (San Mateo, CA). Product code NHI, class 2.
As of Nov 20, 2026, K221425 is an FDA 510(k) held by Dyansys, Inc., substantially equivalent on Sep 13, 2022 after 120 days, with no recalls tied to it in FDA's recall database.
- Review time: 120 days
- Recalls: 0
The Primary Relief is a percutaneous electrical nerve stimulator (PENS) system indicated for up to 3 days for symptomatic relief of post-operative pain following cesarean section delivery or up to 3 days adjunctive symptomatic relief of post-operative pain following cardiac surgery.
- Primary ReliefK213188 · Dyansys, Inc. · Jan 31, 2022
- SPRINT Peripheral Nerve Stimulation (PNS) SystemK223306 · Spr Therapeutics, Inc. · Jan 25, 2023
- ANSiStim-PPK220397 · Dyansys, Inc. · May 12, 2022
- Primary ReliefK213188 · Dyansys, Inc. · Jan 31, 2022
- First ReliefK212859 · Dyansys, Inc. · Dec 20, 2021
- SPRINT PNS SystemK211801 · Spr Therapeutics, Inc. · Oct 13, 2021
- SPRINT PNS SystemK202660 · Spr Therapeutics, Inc. · Jan 22, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- May 16, 2022
- Review panel
- Neurology
- Regulation
- 21 CFR 882.5890
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files